PUBLISHED ON: June 1, 2015 | Duration: 6 min, 51 sec
Uday Baldota, CEO of Sun Pharma, said fourth quarter profit have been impacted by pricing pressure and supply constraints. The company was expecting approvals for some new products, which did not materialise leading to lower sales, Mr Baldota added.
